Exodus Point Capital Management, LP Eq Rx, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$1.66 - $2.31 $22,891 - $31,854	13,790 New	13,790 $31,000
Q2 2022 Aug 19, 2022	SELL	$3.2 - $5.69 $1.22 Million - $2.18 Million	-382,721 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.8 - $7.39 $916,162 - $2.42 Million	327,201 Added 589.34%	382,721 $1.58 Million
Q4 2021 Feb 11, 2022	BUY	$5.92 - $9.98 $328,678 - $554,089	55,520 New	55,520 $379,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.